Surowy proszek propionianu Drostanolonu is a high-purity steroidal raw material also known as Dromostanolone Propionate and Masteron Propionate. AAS Raw Pharma supplies white or almost white crystalline powder with a stated minimum assay of 99.7% do kwalifikowanych badań laboratoryjnych, analytical testing, rozwój metody, reference work, i prawnie autoryzowaną produkcję farmaceutyczną.
Each commercial enquiry can be assessed according to the required quantity, miejsce docelowe, dokumentacja, packaging format, and intended lawful application. Batch-specific quality records may be requested before purchase, subject to availability.
Ważna informacja: This product is a bulk chemical raw material. Nie jest to gotowy lek, sterylny preparat do wstrzykiwań, suplement diety, lub produkt konsumencki, and it is not intended for direct human or veterinary use. Drostanolone Propionate is controlled or otherwise regulated in many jurisdictions. The buyer is responsible for confirming that purchase, posiadanie, przywóz, transport, składowanie, przetwarzanie, and use are lawful.
Surowy proszek propionianu Drostanolonu is the propionate ester of drostanolone, also called dromostanolone. Drostanolone is a synthetic steroidal compound structurally related to dihydrotestosterone. Esterification with propionic acid produces a chemically distinct substance with its own molecular formula, masa cząsteczkowa, Numer CAS, i profil analityczny.
The compound is widely recognised under the name Masteron. Other names appearing in scientific databases, historical records, and commercial catalogues include Dromostanolone Propionate, Drolban, Masterid, Masteril, Prometholon, and 17-beta-hydroxy-2-alpha-methyl-5-alpha-androstan-3-one propionate.
AAS Raw Pharma supplies the substance strictly as a raw material for qualified professional customers. The powder has not been formulated into a finished product and must not be interpreted as ready for injection, ingestion, personal use, or therapeutic administration.
| Specyfikacja | Product information |
|---|---|
| Nazwa produktu | Surowy proszek propionianu Drostanolonu |
| Alternatywna nazwa | Dromostanolone Propionate |
| Powszechna nazwa rynkowa | Masteron, Masteron Propionian |
| Nazwa chemiczna | 17-beta-hydroxy-2-alpha-methyl-5-alpha-androstan-3-one propionate |
| Numer CAS | 521-12-0 |
| Numer EINECS | 208-303-1 |
| NIEKTÓRE | X20UZ57G4O |
| Formuła molekularna | C23H36O3 |
| Masa cząsteczkowa | 360.53 g/mol |
| Deklarowana czystość | 99.7% minimum, podlega dokumentacji zbiorczej |
| Wygląd | Biały lub prawie biały krystaliczny proszek |
| Forma fizyczna | Krystaliczne ciało stałe |
| Podana ocena | Stopień surowca farmaceutycznego |
| Składowanie | Sealed, chroniony przed światłem, and stored according to batch documentation |
| Opakowanie | Szczelnie zamykana torebka foliowa, rigid protective container, lub zatwierdzone opakowanie zbiorcze |
| Dokumentacja | Certyfikat certyfikatu i dokumenty techniczne dotyczące konkretnej partii, jeśli są dostępne |
| Docelowi użytkownicy | Wykwalifikowane laboratoria, instytucje, i autoryzowanych producentów |
| Direct human use | Niedozwolone; to nie jest gotowy produkt |
Numer CAS, wzór molekularny, and molecular weight are independently supported by the FDA’s substance record, Książka internetowa NIST dotycząca chemii, and recognised analytical-reference suppliers.
Specifications published on the website are general commercial information. Final product acceptance should be based on the corresponding batch label, Certyfikat analizy, purchase specification, and the customer’s independent quality procedures.
Drostanolone Propionate Raw Powder is identified by CAS 521-12-0 and the formula C23H36O3. Its molecular weight is approximately 360.53 g/mol. The FDA’s substance database lists Dromostanolone Propionate as the preferred substance name and identifies 17-beta-hydroxy-2-alpha-methyl-5-alpha-androstan-3-one propionate as a recognised chemical name.
These identifiers are important because informal names such as Masteron can be ambiguous in purchasing records. A professional quotation, purchase order, shipping document, or receiving record should identify the product by its full chemical name and CAS number.
The substance is an esterified steroidal compound rather than a formulated medicine. Its chemical identity does not establish that a particular commercial batch meets any pharmacopeial, manufacturing, czystość, sterylność, or regulatory standard. Those characteristics must be established separately through documentation and testing.
Buyers may encounter this material under several alternative names:
The NIST Chemistry WebBook records several of these historical and chemical synonyms.
For procurement purposes, Surowy proszek propionianu Drostanolonu, CAS 521-12-0 is the clearest description. Using both the full name and CAS number reduces the risk of confusion with Drostanolone Enanthate, unesterified drostanolone, or unrelated steroidal raw materials.
AAS Raw Pharma opisuje produkt jako biały lub prawie biały krystaliczny proszek. An established analytical-reference supplier similarly identifies Drostanolone Propionate as a crystalline solid.
Appearance can be useful during receiving inspection, but it cannot by itself confirm identity, czystość, analiza, authenticity, or suitability. Many unrelated chemical materials may have a similar colour and physical form.
Professional customers should compare the product label and batch number with the accompanying documentation and perform appropriate incoming-material testing where required by their quality system.
The AAS Raw Pharma specification lists a minimum purity of 99.7%, subject to confirmation in the documentation for the batch supplied. Purity should not be assessed from appearance, supplier reputation, or a generic website claim alone.
A meaningful assay statement depends on several factors:
Customers requiring a particular assay should request the current batch COA before completing an order. Independent confirmation may also be appropriate depending on the intended application and the receiving organisation’s procedures.
A Certyfikat analizy, commonly abbreviated as COA, is a batch-specific quality document. Depending on the specification and tests performed, a COA for Drostanolone Propionate raw material may include:
An analytical-reference supplier’s published COA demonstrates the value of reporting individual identity and quality tests rather than relying only on a headline purity percentage. Jej przykładem jest identyfikacja w podczerwieni, spektrometria mas, nuclear magnetic resonance, melting-point, rotation, and purity results. Those results apply to that supplier’s specific lot and must not be represented as results for AAS Raw Pharma material.
Customers should verify that the lot number on any AAS Raw Pharma COA matches the product packaging. A COA belonging to another supplier or batch cannot substantiate the quality of the material offered here.
A comprehensive raw-material evaluation can involve more than assay testing. Depending on the agreed specification and intended professional application, quality control may examine:
The presence or absence of a particular test must be confirmed from the actual batch documentation. AAS Raw Pharma should not claim HPLC, GC-MS, NMR, heavy metal, resztkowy rozpuszczalnik, sterylność, microbiological, or pharmacopeial testing unless that test appears in the relevant quality records.
Customers operating under formal quality systems should establish their own approved supplier, próbowanie, kwarantanna, testowanie, release, deviation, and record-retention procedures.
The phrase klasa farmaceutyczna is frequently used by raw-material suppliers, but it should be supported by a defined and verifiable specification. It does not automatically mean that the powder complies with USP, BP, PE, IP, GMP, FDA, MHRA, or another regulatory framework.
A product described as meeting an enterprise or in-house standard has been evaluated against the supplier’s own specification. Customers should request that specification and compare it with their technical, regulatory, and manufacturing requirements.
Avoid making any of the following claims unless documentary evidence is available:
Using precise, supportable language increases credibility and reduces the risk of misleading customers or search engines.
Drostanolone Propionate and Drostanolone Enanthate share the drostanolone parent structure, but they contain different ester groups. They are separate chemical substances with different identifiers and molecular characteristics.
| Funkcja | Drostanolone Propionate | Drostanolone Enanthate |
|---|---|---|
| Parent structure | Drostanolone | Drostanolone |
| Grupa estrowa | Propionian | Enanthate |
| Powszechny skrót | Masteron P | Masteron E |
| Numer CAS | 521-12-0 | 13425-31-5 |
| Formuła molekularna | C23H36O3 | C27H44O3 |
| Masa cząsteczkowa | 360.53 g/mol | Około 416.6 g/mol |
| Ten sam surowiec | NIE | NIE |
| Wymienny | NIE | NIE |
A buyer requesting Masteron powder should specify which ester is required. The safest procurement description for this page is Surowy proszek propionianu Drostanolonu, CAS 521-12-0.
Drostanolone Propionate has appeared historically under names such as Masteron and Drolban. It was previously investigated and used in medical contexts, including historical treatment of certain breast cancers.
That history does not establish a current approved indication for the raw material offered by AAS Raw Pharma. Medical practices, product approvals, and legal classifications vary by country and change over time. A raw chemical ingredient must never be presented as an approved medicine merely because the compound has a history of pharmaceutical use.
This product page therefore does not make claims concerning cancer treatment, cholesterol reduction, hormonal therapy, wyniki sportowe, utrata tłuszczu, diuresis, or muscle development.
Subject to customer qualification and local law, Drostanolone Propionate raw powder may be relevant to professional work such as:
One analytical supplier describes Drostanolone Propionate raw powder as suitable for analytical method development, validation, and quality-control applications.
The availability of a raw material does not authorise any particular application. Each customer is responsible for determining whether its organisation, obiekt, personel, and intended activity satisfy relevant laws and licence requirements.
Surowy proszek propionianu Drostanolonu is not ready for injection. A crystalline chemical ingredient is fundamentally different from a sterile, finished pharmaceutical product.
Manufacturing an injectable medicine requires controls that may include:
A purity result, even when high, nie wykazuje sterylności, wolność od endotoksyn, przydatność do wstrzykiwań, bezpieczeństwo kliniczne, lub zatwierdzenie organów regulacyjnych. AAS Raw Pharma does not provide home-manufacturing, konwersja, brewing, filtrowanie, zastrzyk, or self-administration instructions.
The supplied content recommends shaded, confined preservation. In clearer commercial language, this means keeping the material sealed, chroniony przed światłem, and secured against unauthorised access.
Published reference products do not all use the same storage temperature. Listy substancji chemicznych Cayman -20 stopnie C dla swojego standardu analitycznego, while LGC listings for other reference-standard formats show refrigerated conditions such as +4 stopnie C Lub +5 stopnie C.
These differences illustrate why a customer should follow the label, stability information, and documentation supplied with the exact AAS Raw Pharma batch. General storage practices include:
Do not assign a shelf life or storage temperature unless it is supported by batch-specific or product-specific stability information.
Drostanolone Propionate Raw Powder is a biologically active and potentially regulated substance. It should be handled only by trained personnel in an appropriate professional environment.
A workplace risk assessment should address:
Drostanolone Propionate Raw Powder must not be tasted, połknięty, deliberately inhaled, wstrzyknięty, lub nakładać bezpośrednio na ciało. Keep it away from children, unauthorised persons, household areas, food, beverages, and animal supplies.
If accidental exposure occurs, follow the facility’s emergency procedure and seek appropriate professional medical advice. The applicable Safety Data Sheet should be available to personnel before the package is opened.
AAS Raw Pharma can assess packaging requirements according to order quantity, miejsce docelowe, and approved use. Possible configurations may include:
Packaging should support identity, traceability, containment, and protection during normal transport and storage. A package label should identify the product, batch, ilość, oraz odpowiednie informacje dotyczące obsługi.
The final packaging method must comply with applicable carrier, eksport, import, i wymagania dotyczące miejsca docelowego. AAS Raw Pharma nie oferuje produktów ukrytych, fałszywie zadeklarowane, or deliberately mislabeled shipments.
Próbki mogą być dostępne w kwalifikowanych laboratoriach, instytucje, and authorised commercial buyers, podlega inwentaryzacji, zamierzone zastosowanie, destination laws, and customer verification. Sample availability and charges should be confirmed before an order is placed.
Aby uzyskać próbkę lub wycenę zbiorczą, customers should provide:
Larger or recurring requirements may be discussed separately. Dostępność, zdolności produkcyjne, lead time, minimalna ilość zamówienia, and price should be confirmed in a formal quotation rather than assumed from general website copy.
AAS Raw Pharma wspiera wykwalifikowanych klientów poszukujących udokumentowanych surowców steroidowych do zgodnych z prawem zastosowań profesjonalnych.
The product has a stated minimum purity of 99.7%, subject to the analytical results and documentation for the supplied batch.
Direct commercial sourcing can support competitive quotations for approved orders. Ostateczna cena uzależniona jest od ilości, batch availability, testowanie, dokumentacja, opakowanie, i miejsce docelowe.
Klienci mogą poprosić o dostępny certyfikat COA, SDS, specyfikacja, and other technical information for the current batch before purchase.
Próbka, rozwój, and bulk requirements may be assessed according to stock, kwalifikacja klienta, i obowiązujące przepisy.
Packaging can be selected to protect the powder and maintain product and batch identification throughout lawful storage and transport.
AAS Raw Pharma can review delivery options for destinations where exportation, transport, przywóz, posiadanie, and intended use are permitted.
Support is available for product specifications, dokumentacja, quotation terms, opakowanie, and shipment questions. Customers should report any discrepancy promptly with the relevant order and batch information.
To request a quotation for Surowy proszek propionianu Drostanolonu, provide complete and accurate purchasing details:
AAS Raw Pharma może zażądać dodatkowych informacji przed przyjęciem zamówienia. Submission of an enquiry does not guarantee product availability, shipment, odprawa celna, or order approval.
International delivery may be considered where the shipment is lawful and accepted by the chosen carrier. Possible logistics providers may include DHL, FedEx, UPS-em, TNT, EMS, or an approved freight service, depending on route and product classification.
Carrier availability varies according to destination, ilość, dokumentacja, and applicable transport restrictions. The mention of a carrier does not guarantee that it will accept every shipment.
The customer is responsible for verifying:
AAS Raw Pharma does not guarantee customs clearance and does not falsify labels, wartości, descriptions, faktury, or declarations to avoid inspection.
Drostanolone Propionate raw Powder is controlled in a number of jurisdictions. Cayman Chemical identifies it as a Schedule III compound in the United States and restricts its reference product to research and forensic applications.
Its classification in other countries may differ. Depending on location, purchasing or possessing the compound may require:
Customers must obtain independent legal and regulatory advice where necessary. A product listing does not represent confirmation that the substance may be bought, importowany, or used in a particular jurisdiction.
This page provides technical and commercial information about a raw chemical ingredient. It is not medical advice and does not recommend Drostanolone Propionate raw powder for bodybuilding, cutting, definicja mięśnia, wyniki sportowe, strength retention, zarządzanie wagą, cancer treatment, or any personal purpose.
Dosage instructions such as 200-800 mg per week have intentionally been excluded. Such guidance is inappropriate for a bulk raw powder and could encourage unsafe or unlawful self-administration.
AAS Raw Pharma nie twierdzi, że jest to surowiec diagnozujący, smakołyki, leczy, lub zapobiega jakiejkolwiek chorobie. Any legitimate treatment decision must involve a licensed healthcare professional and a lawfully authorised finished medicinal product.
Surowy proszek propionianu Drostanolonu is the crystalline raw form of the propionate ester of drostanolone. It is intended for qualified research, analityczny, reference, and other lawfully authorised professional applications.
Masteron is a widely recognised trade or market name associated with Drostanolone Propionate raw powder. The raw powder offered on this page is not a finished branded medicine.
Dromostanolone Propionate raw powder is an alternative spelling and recognised name for Drostanolone Propionate. Both refer to CAS 521-12-0.
The CAS Registry Number for Drostanolone Propionate raw Powder is 521-12-0.
Wzór molekularny to C23H36O3.
Masa cząsteczkowa wynosi w przybliżeniu 360.53 g/mol.
The AAS Raw Pharma specification describes it as a white or almost white crystalline powder.
The stated minimum purity is 99.7%, subject to the COA or other analytical documentation for the supplied batch.
Batch-specific documentation may be available on request. Klienci powinni potwierdzić dokładny certyfikat COA, SDS, or specification provided with the relevant lot.
AAS Raw Pharma wymienia go jako surowiec farmaceutyczny. Customers should review the applicable specification and supporting documents to determine whether it satisfies their requirements. This description does not mean the powder is a finished or approved medicine.
No sterility claim should be assumed. Chyba, że wyprodukowano partię, przetestowany, and released under a documented sterile specification, traktować go jako surowiec niesterylny.
NIE. Raw powder is not a finished injectable preparation and must not be injected or directly administered.
NIE. Nie jest przeznaczony do bezpośredniego spożycia, zastrzyk, samodzielne administrowanie, kulturystyka, or veterinary use.
NIE. Dosing and steroid-cycle instructions are inappropriate for a bulk raw material. Medical guidance must come from a licensed healthcare professional using an authorised finished product.
They contain different ester groups and are distinct chemical substances with different CAS numbers, formuły, i masy cząsteczkowe. They are not interchangeable raw materials.
Samples may be available for qualified customers, depending on inventory, zamierzone zastosowanie, regulamin miejsca docelowego, weryfikacja, i warunki handlowe.
Bulk enquiries may be assessed according to quantity, magazyn, zdolności produkcyjne, dokumentacja, miejsce docelowe, and legal requirements.
Available options may include sealed foil bags, pojemniki ochronne, lub zatwierdzone opakowanie zbiorcze. The final format depends on quantity and transport requirements.
Keep it tightly sealed, chroniony przed światłem, and secured against unauthorised access. Follow the exact temperature and storage conditions stated on the product label and batch documentation.
International shipment may be possible where the transaction and transport are lawful. The buyer must verify import, posiadanie, licensing, przewoźnik, and customs requirements.
NIE. Customs clearance is controlled by the relevant authorities. The buyer remains responsible for permits, deklaracje, obowiązki, podatki, and destination-country compliance.
Podaj ilość, miejsce docelowe, szczegóły organizacji, zamierzony, zgodny z prawem użytek, preferred packaging, i wymaganą dokumentację. AAS Raw Pharma can then evaluate the enquiry.
| Specyfikacja | Product information |
|---|---|
| Nazwa produktu | Surowy proszek propionianu Drostanolonu |
| Alternatywna nazwa | Dromostanolone Propionate |
| Powszechna nazwa rynkowa | Masteron, Masteron Propionian |
| Nazwa chemiczna | 17-beta-hydroxy-2-alpha-methyl-5-alpha-androstan-3-one propionate |
| Numer CAS | 521-12-0 |
| Numer EINECS | 208-303-1 |
| NIEKTÓRE | X20UZ57G4O |
| Formuła molekularna | C23H36O3 |
| Masa cząsteczkowa | 360.53 g/mol |
| Deklarowana czystość | 99.7% minimum, podlega dokumentacji zbiorczej |
| Wygląd | Biały lub prawie biały krystaliczny proszek |
| Forma fizyczna | Krystaliczne ciało stałe |
| Podana ocena | Stopień surowca farmaceutycznego |
| Składowanie | Sealed, chroniony przed światłem, and stored according to batch documentation |
| Opakowanie | Szczelnie zamykana torebka foliowa, rigid protective container, lub zatwierdzone opakowanie zbiorcze |
| Dokumentacja | Certyfikat certyfikatu i dokumenty techniczne dotyczące konkretnej partii, jeśli są dostępne |
| Docelowi użytkownicy | Wykwalifikowane laboratoria, instytucje, i autoryzowanych producentów |
| Direct human use | Niedozwolone; to nie jest gotowy produkt |
